Immune Effector Cell Associated Neurotoxicity Syndrome
📧 Sign up to get email alerts when something new happens for Immune Effector Cell Associated Neurotoxicity Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Assessing DCog Short for Neurotoxicity in CAR-T [NA]
A clinical trial update describes assessing DCog Short for identifying neurotoxicity related to CAR-T therapy, with the study not yet recrui…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy [Phase 2]
A Phase 2 clinical trial update notes evaluation of siltuximab for treating cytokine release syndrome (CRS) and ICANS related to CAR-T cell …
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study [Phase 1]
Phase I study evaluating adjunctive methylene blue for immunotherapy-related cytokine release syndrome and ICANS; recruiting in China.
-
CLINICAL_TRIALS withdrawal · 2025-03-03Clinical Trial Update: Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM [Phase 2]
A Phase 2 trial evaluating siltuximab to prevent cytokine release syndrome in patients with relapsed/refractory multiple myeloma treated wit…